·     Meeting Highlights   ·     Presentations     ·     Speakers     ·     Location     ·     Sponsorship   ·


CHC 2017 Presentations for Download

 

DAY ONE


Chronic Lymphocytic Leukemia (CLL)
Chair – Dr. Graeme Fraser

Update on Standard Therapy of CLL  – Dr. Graeme Fraser
Management of Ibrutinib Failure – Dr. Carolyn Owen


Hodgkin’s Lymphoma
Chair – Dr. Michael Crump

Current Management of Localized HL – Dr. Michael Crump
Risk Adapted Therapy in Advanced HL: Current Approaches – Dr. Jonathan Friedberg


Non-Hodgkin’s Lymphoma
Chair: Dr. Laurie Sehn

Evolving Standards in Follicular Lymphoma – Dr. Laurie Sehn
Novel Therapy in Follicular Lymphoma – Dr. Nathan Fowler
The Genomics of Follicular Lymphoma – Dr. Robert Kridel


 

Leukemia/Myelodysplastic Syndrome (MDS)
Chair: Dr. Rena Buckstein

Treatment in 2017 – “Nuts and Bolts” of AML Therapy – Dr. Andre Schuh
The Impact of Somatic Mutations for Patients with MDS – Dr. Michael Rauh
Managing Patients with Azacitidine Failure in MDS – Dr. Mikkael Sekeres


Benign Hematology I
Chair: Dr. Denis Soulieres

Catheter Related Thrombosis – Dr. William Geerts
Current Management of Clinical Hemoglobinopathy – Dr. Denis Soulieres


Immunotherapy

Chair: Dr. Peter Anglin

The Future of Immunotherapy in Lymphoma: Dr. Stephen Ansell


 

DAY TWO

Benign Hematology II
Chair: Dr. Martina Trinkaus

Off Label Evidence for DOACs in Cancer and DOAC Reversal – Dr. Mark Crowther
Review of Erythropoiesis-Stimulating Agents in 2017 – Dr. Martina Trinkaus
The Refractory AIHA Patient – Dr. Claire Dearden


Non-Hodgkin’s Lymphoma II
Chair: Dr. Douglas Stewart

PET in Lymphoma: How to Use New Staging & Response Criteria – Dr. George Mikaeel
Management of Double Hit and Dual Protein Expressing Lymphomas – Dr. Nathalie Johnson
ASCT in Primary and Secondary CNS Lymphoma – Dr. Douglas Stewart


Myeloma
Chair: Dr. Kevin Song

Monoclonal Gammopathies of Renal Significance – Dr. Vincent Rajkumar
Relapsed/Refractory Disease – Dr. Kevin Song


Translational I
Dr. Rob Laister

The Development of CRISPR Based Medicines for the Treatment of Hematological Diseases – Dr. Grant Welstead
Anti-Tumour Immunity: Beyond T-Cells and Checkpoint Blockades – Dr. Connie Krawczyk
Emerging Concepts in Cell Therapy and The Microenvironment – Dr. Rob Laister


Translational II
Chair: Dr. John Kuruvilla

The Tumour Microenvironment of B-Cell Lymphomas – Dr. Christian Steidl
Cellular Therapy and the Future of Allogeneic Steam Cell Transplantation – Dr. John Barrett


Myeloproliferative Neoplasms (MPN)
Chair: Dr. Lynda Foltz

Update on JAK Inhibitors in 2016-2017 – Dr. Ayalew Tefferi
Case Studies in MPN – Dr. Lynda Foltz


 

To view the CHC 2017 Agenda
please download the CHC 2017 Official Mobile App!

 

Click to download on the various devices below:

Click here to download in the Blackberry World store.
Compatible with BlackBerry 10 and higher

Click here to download in the Apple App store
Compatible with iOS 7.0 and higher

Click here to download in the Google Play store.
Compatible with Android 2.3.3 and higher

Click here to view the desktop version of the CHC app.

 

Having trouble downloading the app?